Related Experiment Videos
[Increased liver density in computed tomography as a result of anti-arrhythmia therapy with amiodarone]
1Institut für Radiologische Diagnostik, Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Insights
Amiodarone therapy significantly increases liver density on CT scans, with density rising with treatment duration. This finding is crucial for diagnosing liver conditions in patients on amiodarone.
Area of Science:
- Radiology
- Pharmacology
- Hepatology
Background:
- Amiodarone is an antiarrhythmic drug with known potential for various toxicities.
- Hepatic side effects of amiodarone are documented, but changes in liver density on CT scans require further investigation.
Purpose of the Study:
- To evaluate if amiodarone therapy alters hepatic density as measured by CT scans.
- To compare liver density in amiodarone recipients versus a control group.
Main Methods:
- Computed tomography (CT) scans were used to assess hepatic density in 31 patients on amiodarone (categorized by therapy duration) and 15 controls.
- Liver density was quantified using Hounsfield units (HU).
Main Results:
- Patients on amiodarone exhibited significantly higher mean liver density (77.9 HU) compared to controls (56.6 HU).
- Liver density increased with the duration of amiodarone therapy, from short-term (64.8 HU) to long-term (85.0 HU).
Conclusions:
- Amiodarone therapy is associated with a significant increase in hepatic density on CT scans.
- This elevated liver density should be considered in the differential diagnosis of hepatopathies presenting with increased density.
Purpose:
To assess whether the hepatic density on CT scans of patients receiving amiodarone therapy differs significantly from the hepatic density of a control group not receiving the drug.
Methods:
Hepatic density was assessed by CT in 31 patients receiving amiodarone, 7 receiving short-term (12-14 days), 8 receiving mid-term (20-89 days) and 16 receiving long-term therapy (3-26 months), as well as in a control group of 15 patients.
Results:
Mean liver density of all patients under amiodarone therapy (77.9 +/- 11.7 HU) was significantly higher (p < 0.005) than in the control group (56.6 +/- 2.8 HU). The smallest increase in density was found in patients with short-term therapy (64.8 +/- 3.4 HU; p < 0.05), the greatest increase in patients with long-term therapy (85.0 +/- 8.9 HU; p < 0.001).
Conclusion:
In patients receiving amiodarone therapy, a significantly increased hepatic density on CT scans is observed. This finding has to be considered as a differential diagnosis to other hepatopathies with increased density of the liver.